These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 15066462

  • 1. Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study.
    Cucinelli F, Soranna L, Perri C, Barini A, Cento RM, Mancuso S, Lanzone A.
    Fertil Steril; 2004 Apr; 81(4):1047-54. PubMed ID: 15066462
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term naltrexone treatment reduces the exaggerated insulin secretion in patients with polycystic ovary disease.
    Fulghesu AM, Lanzone A, Cucinelli F, Caruso A, Mancuso S.
    Obstet Gynecol; 1993 Aug; 82(2):191-7. PubMed ID: 8336863
    [Abstract] [Full Text] [Related]

  • 4. Naloxone decreases insulin secretion in hyperinsulinemic postmenopausal women and may positively affect hormone replacement therapy.
    Cucinelli F, Soranna L, Perri C, Romualdi D, Barini A, Mancuso S, Lanzone A.
    Fertil Steril; 2002 Nov; 78(5):1017-24. PubMed ID: 12413987
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relationship between the hyperinsulinemic-euglycaemic clamp and a new simple index assessing insulin sensitivity in overweight and obese postmenopausal women.
    Bastard JP, Vandernotte JM, Faraj M, Karelis AD, Messier L, Malita FM, Garrel D, Prud'homme D, Rabasa-Lhoret R.
    Diabetes Metab; 2007 Sep; 33(4):261-8. PubMed ID: 17499540
    [Abstract] [Full Text] [Related]

  • 8. Effect of hormone therapy on the enteroinsular axis.
    Sztefko K, Rogatko I, Milewicz T, Józef K, Tomasik PJ, Szafran Z.
    Menopause; 2005 Sep; 12(5):630-638. PubMed ID: 16145319
    [Abstract] [Full Text] [Related]

  • 9. The differential effect of the phytoestrogen genistein on cardiovascular risk factors in postmenopausal women: relationship with the metabolic status.
    Villa P, Costantini B, Suriano R, Perri C, Macrì F, Ricciardi L, Panunzi S, Lanzone A.
    J Clin Endocrinol Metab; 2009 Feb; 94(2):552-8. PubMed ID: 19017760
    [Abstract] [Full Text] [Related]

  • 10. [The effects of ethinyl estradiol on glucose metabolism in postmenopausal women].
    Wu J, Bi Y, Wang H.
    Zhonghua Fu Chan Ke Za Zhi; 1997 Sep; 32(9):528-31. PubMed ID: 9639751
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A comparison of oral and transdermal short-term estrogen therapy in postmenopausal women with metabolic syndrome.
    Chu MC, Cosper P, Nakhuda GS, Lobo RA.
    Fertil Steril; 2006 Dec; 86(6):1669-75. PubMed ID: 17074346
    [Abstract] [Full Text] [Related]

  • 14. Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study.
    Romualdi D, Costantini B, Campagna G, Lanzone A, Guido M.
    Fertil Steril; 2008 Nov; 90(5):1826-33. PubMed ID: 18166189
    [Abstract] [Full Text] [Related]

  • 15. SHBG levels correlate with insulin resistance in postmenopausal women.
    Akin F, Bastemir M, Alkiş E, Kaptanoglu B.
    Eur J Intern Med; 2009 Mar; 20(2):162-7. PubMed ID: 19327605
    [Abstract] [Full Text] [Related]

  • 16. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
    Davis SR, Stuckey BG, Norman RJ, Papalia MA, Drillich A, Bell RJ.
    Menopause; 2008 Mar; 15(6):1065-9. PubMed ID: 18806686
    [Abstract] [Full Text] [Related]

  • 17. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion.
    Cucinelli F, Paparella P, Soranna L, Barini A, Cinque B, Mancuso S, Lanzone A.
    Eur J Endocrinol; 1999 Mar; 140(3):215-23. PubMed ID: 10216516
    [Abstract] [Full Text] [Related]

  • 18. The effect of 6 months supplementation with conjugated linoleic acid on insulin resistance in overweight and obese.
    Syvertsen C, Halse J, Høivik HO, Gaullier JM, Nurminiemi M, Kristiansen K, Einerhand A, O'Shea M, Gudmundsen O.
    Int J Obes (Lond); 2007 Jul; 31(7):1148-54. PubMed ID: 17031391
    [Abstract] [Full Text] [Related]

  • 19. Effects of low and high dose oestradiol and dydrogesterone therapy on insulin and lipoprotein metabolism in healthy postmenopausal women.
    Godsland IF, Manassiev NA, Felton CV, Proudler AJ, Crook D, Whitehead MI, Stevenson JC.
    Clin Endocrinol (Oxf); 2004 May; 60(5):541-9. PubMed ID: 15104556
    [Abstract] [Full Text] [Related]

  • 20. Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism.
    Villa P, Valle D, Mancini A, De Marinis L, Pavone V, Fulghesu AM, Mancuso S, Lanzone A.
    Fertil Steril; 1999 Jan; 71(1):115-21. PubMed ID: 9935127
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.